Company Filing History:
Years Active: 2019-2025
Title: Innovations of Ryan Bjordahl in Immunotherapy
Introduction
Ryan Bjordahl, based in San Diego, California, is an accomplished inventor recognized for his significant contributions to the field of immunotherapy. With a portfolio that includes 18 patents, Bjordahl has made considerable strides in enhancing various therapeutic approaches, particularly through the application of induced pluripotent stem cells (iPSCs).
Latest Patents
Bjordahl's recent patents showcase groundbreaking methods and compositions for advancing cancer therapies. One notable patent focuses on "Immunotherapies using enhanced iPSC derived effector cells," which outlines techniques for obtaining enhanced derivative effector cells from genomically engineered iPSCs. These cells possess stable genomic modifications that yield improved therapeutic effects. Another key patent emphasizes "Compositions and methods for immune cell modulation in adoptive immunotherapies," identifying compounds that increase the efficacy of T, NK, and NKT cells in cell therapies.
Career Highlights
Currently, Ryan Bjordahl is associated with Fate Therapeutics, Inc., a leading biotech company dedicated to developing transformative cell therapies. His role at the company allows him to drive innovations that are set to improve patient outcomes significantly. Throughout his career, Bjordahl has been at the forefront of research that merges cutting-edge science with practical therapeutic applications.
Collaborations
At Fate Therapeutics, Bjordahl collaborates with esteemed colleagues including Bahram Valamehr and Tom Tong Lee. Together, they work on pioneering projects that harness the power of cellular engineering to develop novel immunotherapeutic approaches.
Conclusion
Ryan Bjordahl stands out as an influential inventor in the field of immunotherapy, with a robust portfolio of patents that pave the way for new treatments. His innovative work, combined with collaborations at Fate Therapeutics, promises to make a significant impact on the future of medical therapies aimed at combating diseases like cancer.